Fredun Pharmaceuticals Ltd Stock News
Fredun Pharmaceuticals Ltd Share Price
Detail Overview₹1,693.90
-14.10(-0.83%)
As on 20 Nov 2026 at 15:59
As of 20 Nov 2026 at 15:59, Fredun Pharmaceuticals Ltd is trading at ₹1,693.90. The 52-week range stands at ₹453.59–₹1,735.00, with a market cap of ₹2.90 thousand crore. At a P/E of 54.17 and a dividend yield of 0.01%, it is a small-cap stock in the Pharmaceuticals sector.
FREDUN Price Chart
Market Cap
₹2.90K Cr
PE Ratio
54.17
ROCE
20.50%
Fredun Pharmaceuticals Ltd Latest News
View More14 NOV 2026 | Saturday
Fredun Pharmaceuticals' board reviewed a monitoring report for the quarter ended September 30, 2026
14 NOV 2026 | Saturday
Fredun Pharmaceuticals confirms Rs 128.78 crore preferential issue use, despite reporting observations
05 OCT 2026 | Monday
Fredun Pharmaceuticals allots shares to warrant holders following board meeting on October 3, 2026
04 OCT 2026 | Sunday
Fredun Pharmaceuticals allotted shares to warrant holders following conversion and shareholder approval
03 OCT 2026 | Saturday
Fredun Pharmaceuticals allotted shares to warrant holders following conversion and shareholder approval
28 SEPT 2026 | Monday
Fredun Pharmaceuticals halts trading for insiders pending financial results announcement
22 SEPT 2026 | Tuesday
Fredun Pharmaceuticals converts warrants, allotting shares to warrant holders and investors
17 SEPT 2026 | Thursday
Fredun Pharmaceuticals allots shares to warrant holders including Alchemy Capital and Ajay Aggarwal
16 SEPT 2026 | Wednesday
Fredun Pharmaceuticals allots shares to warrant holders including Alchemy Capital and Ajay Aggarwal
15 AUG 2026 | Saturday
Fredun Pharmaceuticals confirms Rs 111.53 crore preferential issue use, per Care Ratings